Antibody Expression and Production
โ Scribed by Thomas Jostock (auth.), Mohamed Al-Rubeai (eds.)
- Publisher
- Springer Netherlands
- Year
- 2011
- Tongue
- English
- Leaves
- 349
- Series
- Cell Engineering 7
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly. The importance of antibody applications is reflected in their increasing clinical and industrial applications as well as in the progression of established and emerging production strategies. This volume provides detailed coverage of the generation, optimization, characterization, production and applications of antibody. It provides the necessary theoretical background and description of methods for the expression of antibody in microbial and animal cell cultures and in transgenic animals and plants. There is a strong focus on those issues related to the production of intrabodies, bispecific antibody and antibody fragments and also to novel applications in cancer immunotherapy.
โฆ Table of Contents
Front Matter....Pages i-ix
Expression of Antibody in Mammalian Cells....Pages 1-24
Bioreactor Systems for Producing Antibody from Mammalian Cells....Pages 25-52
Production of Antibody in Insect Cells....Pages 53-76
Production of Monoclonal Antibodies in Glycoengineered Pichia pastoris ....Pages 77-98
Production of Antibodies in Hansenula polymorpha ....Pages 99-119
Production of Antibody by Transgenic Avians....Pages 121-141
Production of Antibodies in Plants....Pages 143-164
Production of Antibody Fab Fragments in Escherichia coli ....Pages 165-178
Intrabody Expression in Mammalian Cells....Pages 179-195
Engineering Antibodies for Cancer Therapy....Pages 197-233
Recombinant Bispecific Antibodies for Cancer Therapy....Pages 235-249
The Role of Glycosylation in Therapeutic Antibodies....Pages 251-292
Quality Issues Arising from Post-translational Modification of Recombinant Antibodies....Pages 293-303
Recovery and Purification of Antibody....Pages 305-340
Back Matter....Pages 341-345
โฆ Subjects
Biomedicine general
๐ SIMILAR VOLUMES
<br> Content: Production of engineered antibodies in myeloma and hybridoma cells : enhancements in gene expression and process design / D.K. Robinson, D. DiStefano, S.L. Gould, G. Cuca, T.C. Seamans, D. Benincasa, S. Munshi, C.P. Chan, J. Stafford-Hollis, G.F. Hollis, D. Jain, K. Ramasubramanyan, G.
<p> During the past ten years, several theories have been proposed on the origin of the diversity of antibodies. George P. Smith presents a critical study of these theories in this detailed treatment of immunological problems from the point of view of molecular genetics. </p> <p> Mr. Smith uses a ne
<p><P>If the antibody industry is to achieve its full potential in the next decade, the individual technical potentials must be exploited, the limitations must be addressed, and lessons learned must be applied both to current purification methods and to the new technologies that continue to emerge.
The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the production of mAb. On September 18, 1997, NIH declined to prohibit the use of mice in mAb production, stating that "the ascites method of mAb produ
Monoclonal antibodies (mAb) are used extensively ั basic biomedical research, in diagnosis of disease, and in treatment of illnesses, such as infections and cancer. Antibodies are important tools used by many investigators in their research and have led to many medical advances.Producing mAb require